(PLBY) Plby - Overview
Stock: Sexual Wellness, Apparel, Media, Spirits, Licensing
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 88.3% |
| Relative Tail Risk | -18.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -32.92 |
| Character TTM | |
|---|---|
| Beta | 0.971 |
| Beta Downside | 0.589 |
| Drawdowns 3y | |
|---|---|
| Max DD | 83.12% |
| CAGR/Max DD | -0.17 |
Description: PLBY Plby January 25, 2026
Playboy, Inc. (NASDAQ: PLBY) is a pleasure-and-leisure company operating globally through three core segments: Licensing (trademark and design rights), Direct-to-Consumer (retail stores, e-commerce, and product lines such as lingerie, intimacy accessories, beauty, and spirits), and Digital Subscriptions & Content (PlayboyPlus.com, Playboy.tv, and other online media). The firm monetizes its iconic brand across apparel, adult products, media, and hospitality collaborations.
In FY 2025 the company reported $511 million of total revenue, with licensing contributing roughly 55 % and DTC sales growing 31 % YoY to $124 million, driven by a 38 % increase in e-commerce transactions. Digital subscription revenue rose 22 % YoY, reaching $38 million, reflecting higher engagement on the PlayboyPlus platform. The gross margin on licensing remained above 80 %, while DTC gross margin improved to 45 % after cost-optimization initiatives.
Key macro drivers include the rebound in consumer discretionary spending in the United States (real retail sales up 4.2 % YoY Q4 2025) and the continued expansion of e-commerce penetration (U.S. online sales now 15 % of total retail). The adult-entertainment sector benefits from a gradual liberalization of content regulations in Europe and Asia, which supports international licensing growth. Conversely, inflationary pressure on discretionary income and potential regulatory scrutiny of adult-content platforms remain downside risks.
For a deeper quantitative assessment, see the ValueRay platform’s detailed valuation model.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -28.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 8.06 > 1.0 |
| NWC/Revenue: -2.48% < 20% (prev 17.45%; Δ -19.93% < -1%) |
| CFO/TA -0.00 > 3% & CFO -1.06m > Net Income -28.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (112.5m) vs 12m ago 50.88% < -2% |
| Gross Margin: 65.54% > 18% (prev 0.57%; Δ 6497 % > 0.5%) |
| Asset Turnover: 61.59% > 50% (prev 58.19%; Δ 3.40% > 0%) |
| Interest Coverage Ratio: -1.47 > 6 (EBITDA TTM -4.12m / Interest Expense TTM 9.73m) |
Altman Z'' -11.59
| A: -0.02 (Total Current Assets 51.3m - Total Current Liabilities 55.5m) / Total Assets 278.3m |
| B: -2.55 (Retained Earnings -710.3m / Total Assets 278.3m) |
| C: -0.05 (EBIT TTM -14.3m / Avg Total Assets 274.9m) |
| D: -2.68 (Book Value of Equity -737.2m / Total Liabilities 274.7m) |
| Altman-Z'' Score: -11.59 = D |
Beneish M -3.25
| DSRI: 0.81 (Receivables 5.53m/6.34m, Revenue 169.3m/158.0m) |
| GMI: 0.86 (GM 65.54% / 56.59%) |
| AQI: 1.17 (AQ_t 0.74 / AQ_t-1 0.63) |
| SGI: 1.07 (Revenue 169.3m / 158.0m) |
| TATA: -0.10 (NI -28.8m - CFO -1.06m) / TA 278.3m) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
What is the price of PLBY shares?
Over the past week, the price has changed by +5.30%, over one month by -14.52%, over three months by +23.26% and over the past year by -20.50%.
Is PLBY a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PLBY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.5 | 57.2% |
| Analysts Target Price | 2.5 | 57.2% |
| ValueRay Target Price | 1.4 | -10.1% |
PLBY Fundamental Data Overview February 02, 2026
P/S = 1.3615
P/B = 44.2682
P/EG = 2.3136
Revenue TTM = 169.3m USD
EBIT TTM = -14.3m USD
EBITDA TTM = -4.12m USD
Long Term Debt = 175.3m USD (from longTermDebt, last quarter)
Short Term Debt = 8.80m USD (from shortTermDebt, last quarter)
Debt = 199.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 172.1m USD (from netDebt column, last quarter)
Enterprise Value = 334.8m USD (162.7m + Debt 199.6m - CCE 27.6m)
Interest Coverage Ratio = -1.47 (Ebit TTM -14.3m / Interest Expense TTM 9.73m)
EV/FCF = -116.8x (Enterprise Value 334.8m / FCF TTM -2.87m)
FCF Yield = -0.86% (FCF TTM -2.87m / Enterprise Value 334.8m)
FCF Margin = -1.69% (FCF TTM -2.87m / Revenue TTM 169.3m)
Net Margin = -17.01% (Net Income TTM -28.8m / Revenue TTM 169.3m)
Gross Margin = 65.54% ((Revenue TTM 169.3m - Cost of Revenue TTM 58.4m) / Revenue TTM)
Gross Margin QoQ = 76.02% (prev 65.40%)
Tobins Q-Ratio = 1.20 (Enterprise Value 334.8m / Total Assets 278.3m)
Interest Expense / Debt = 0.96% (Interest Expense 1.93m / Debt 199.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -11.3m (EBIT -14.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.92 (Total Current Assets 51.3m / Total Current Liabilities 55.5m)
Debt / Equity = 52.91 (Debt 199.6m / totalStockholderEquity, last quarter 3.77m)
Debt / EBITDA = -41.81 (negative EBITDA) (Net Debt 172.1m / EBITDA -4.12m)
Debt / FCF = -60.02 (negative FCF - burning cash) (Net Debt 172.1m / FCF TTM -2.87m)
Total Stockholder Equity = -8.21m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.48% (Net Income -28.8m / Total Assets 278.3m)
RoE = 351.0% (negative equity) (Net Income TTM -28.8m / Total Stockholder Equity -8.21m)
RoCE = -8.56% (EBIT -14.3m / Capital Employed (Equity -8.21m + L.T.Debt 175.3m))
RoIC = -6.70% (negative operating profit) (NOPAT -11.3m / Invested Capital 168.6m)
WACC = 4.68% (E(162.7m)/V(362.4m) * Re(9.49%) + D(199.6m)/V(362.4m) * Rd(0.96%) * (1-Tc(0.21)))
Discount Rate = 9.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 23.59%
Fair Price DCF = unknown (Cash Flow -2.87m)
EPS Correlation: 37.71 | EPS CAGR: -0.56% | SUE: 0.0 | # QB: 0
Revenue Correlation: -46.43 | Revenue CAGR: -27.27% | SUE: -0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=+0.015 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.07 | Chg30d=+0.067 | Revisions Net=+0 | Growth EPS=+147.8% | Growth Revenue=+8.4%